FDA Limits Duration and Usage of Samsca
The US Food and Drug Administration (FDA) has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury, potentially requiring liver transplant or death.
Blood Sugar May Matter for Non-Diabetics
Even without diabetes, low blood sugar levels can lead to some serious risks and health problems. Researchers recently set out to see what these risks were.
First Cord Blood Product Gets FDA Stamp of Approval
For the first time, U.S. Food and Drug Administration officials have given the green light to an umbilical cord blood product that could be used in stem cell transplants for patients with blood cancer, or metabolic or immune disorders.
Surprising Mechanism Aids Cell Self Destruction
Excess amounts of fat and sugar force cells to self destruct when they can no longer stand the toxic environment. Scientists believe they now know why these overloaded cells commit suicide.